Clinical Trial: Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Reporting of Amyloidosis Stem Cell Transplantation Outcomes

Brief Summary: This study examines the value of stem cell transplantation in managing light chain amyloidisis.

Detailed Summary:

  1. How does age at diagnosis affect prognosis in primary amyloidosis?
  2. How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis?
  3. How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis?
  4. How does initial treatment affect prognosis in primary amyloidosis?

4. How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?


Sponsor: Mayo Clinic

Current Primary Outcome: Survival [ Time Frame: up to 8 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Mayo Clinic

Dates:
Date Received: March 15, 2012
Date Started: June 2011
Date Completion:
Last Updated: January 20, 2014
Last Verified: January 2014